Delivery Order SPE2DB22D2206-SPE2DB25FJP41
Award Date 8/22/25
Potential Completion Date 9/15/25
Potential Value $28K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,963.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Gamunex-C 40 gram/400 mL vials. This is a non-set-aside competitive award with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Gamunex-C is an intravenous immunoglobulin therapy commonly used to treat immunodeficiency disorders and other immune-related...
- The Defense Logistics Agency awarded a $41,178.10 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an immune globulin intravenous (human) product used in treating immune deficiency disorders and is a critical pharmaceutical...
- The Defense Logistics Agency awarded a $11,636.00 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) therapy used to treat various immunodeficiency and autoimmune conditions, making it a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of GAMUNEX-C 40 Gram/400 mL vials, valued at $4,654.40 with a firm fixed price structure. This is an unset-aside, competitively awarded contract with an ultimate completion date of August 20, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat primary...
- The Defense Logistics Agency awarded a $23,272.00 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 Gram/400 ML vials. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 3, 2025. GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat various immunological conditions and is a critical pharmaceutical commodity within the federal medical supply chain. The contract is performed at...
- The Defense Logistics Agency awarded a delivery order valued at $4,654.40 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 40 gram/400 mL vials on August 14, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with firm fixed pricing. This is a non-set-aside delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is executing this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,104.70 for GAMUNEX-C 10 gram/100 mL vials on August 19, 2025, with completion expected by September 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) therapeutic used to treat various immune-related conditions, representing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of GAMUNEX-C 10 gram/100 milliliter vials, with a ceiling value of $9,157.05 and an ultimate completion date of August 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin used to treat immunodeficiency and autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $23.6K to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of GAMUNEX-C (20 gram/200 mL vial, 200 mL units). GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat immunodeficiency disorders and other immune-related conditions. This is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing contract vehicle with DLA. The order is scheduled for...